UPDATE : Monday, December 9, 2019
상단여백
Novartis Korea gains approval for skin disease biologic
The Ministry of Food and Drug Safety (MFDS) has approved biologic Xolair to...
by Marian Chu  |  2017-09-07 14:28
라인
Green Cross Cell, Maryland to cooperate for US business
Green Cross Cell, a cell treatment company, announced Wednesday that it has...
by Lee Han-soo  |  2017-09-07 11:18
라인
BMS, Pfizer prove safety for blood-thinning drug in P4 trial
Bristol-Myers Squibb and Pfizer said Wednesday their blood thinner drug Eli...
by Marian Chu  |  2017-09-06 17:40
라인
Novartis’ Revolade proved effective for seniors
Novartis Korea said Tuesday additional data analysis from its EXTEND clinic...
by Marian Chu  |  2017-09-06 12:53
라인
GemVax & KAEL names Song as new CEO
GemVax & KAEL has appointed Song Hyoung-gon 송형곤 as their new chief executiv...
by Lee Han-soo  |  2017-09-06 10:47
라인
Will Amgen’s Repatha succeed in the Korean market?
Amgen Korea released its cholesterol-lowering drug Repatha in the domestic ...
by Marian Chu  |  2017-09-06 09:07
라인
Pfizer Korea releases new tool for rheumatism injection
Pfizer Korea said Tuesday it has released an injection tool and program cal...
by Marian Chu  |  2017-09-05 17:22
라인
‘Mooncare’ helps bio, pharmaceutical stocks overcome NK risks
Amid escalating North Korea risks caused by the North’s nuclear and missile...
by Nam Doo-hyun  |  2017-09-05 16:45
라인
Celgene Korea names new CEO
Celgene Korea has elected Ham Tae-jin as its new CEO, the company said Tues...
by Marian Chu  |  2017-09-05 14:22
라인
Korean start-up Sky Labs wins in Bayer innovation program
Bayer (CEO: Werner Baurmann) said Tuesday it selected four startups, includ...
by Marian Chu  |  2017-09-05 11:11
라인
Ahngook gets state support for new drug
Ahngook Pharmaceuticals said Tuesday it has secured the government’s suppor...
by Lee Han-soo  |  2017-09-05 10:53
라인
Celgene’s leukemia drug gets extended insurance coverage
Celgene said Monday its myelodysplastic syndrome (MS) treatment Vidaza (Ing...
by Lee Han-soo  |  2017-09-04 17:34
라인
Korea UCB gets approval for hemophilia treatment
Korea UCB (CEO: Lee Young-joo) said Tuesday the Ministry of Food and Drug S...
by Marian Chu  |  2017-09-04 15:32
라인
Bluegreen, Haim Bio sign strategic alliance agreement
Haim Bio 하임바이오, a venture company for new bio drugs, entered into a strateg...
by Lee Han-soo  |  2017-09-04 15:11
라인
Roche gets insurance coverage for pregnancy complication detection test
Roche Diagnostics Korea said its blood test for a pregnancy complication ca...
by Marian Chu  |  2017-09-04 11:45
라인
CJ Healthcare submits new drug application for Tegoprazan
CJ Healthcare said Monday it has submitted new drug application with the Mi...
by Lee Han-soo  |  2017-09-04 11:32
라인
Eisai gets insurance coverage for thyroid cancer drug
Eisai Korea said Friday its thyroid cancer treatment Lenvima (ingredient: l...
by Marian Chu  |  2017-09-01 13:59
라인
Quratis applies for P2 clinical trial for Korea’s first adult tuberculosis vaccine
Quratis announced Wednesday that the company had applied for the phase 2 of...
by Lee Han-soo  |  2017-09-01 12:04
라인
Gilead, Yuhan to jointly promote hepatitis C drugs
Gilead Sciences Korea and Yuhan Corporation said Thursday the two companies...
by Marian Chu  |  2017-08-31 17:08
라인
Abbvie gets approval for phase 3 clinical trials to treat Crohn’s disease
Abbvie’s new drug Risankizumab, being developed to treat the Crohn’s diseas...
by Lee Hye-seon  |  2017-08-31 15:49
-이전81828384858687888990-
Celltrion unveils long-term P3 trial results for Truxima in USCelltrion unveils long-term P3 trial results for Truxima in US
여백
Most viewed
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top